Delivery Order SPE2DB25D3003-SPE2DB25FPXFF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,059.60 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors valued at $4,852.65 on August 27, 2025, with completion expected by August 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $11,598.25 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 26, 2025, with a completion date of September 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award for continuous glucose monitoring supplies to support military and federal healthcare operations. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,100.64 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors on August 25, 2025, with an ultimate completion date of August 26, 2025. This is a firm fixed price, non-set-aside contract for delivery to the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a discrete procurement of continuous glucose monitoring sensors...
- The Defense Logistics Agency awarded a $8,587.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-set-aside contract represents a single delivery order for continuous glucose monitoring sensors to support federal medical supply needs. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,578.56 in Freestyle Libre 3 Plus continuous glucose monitoring sensors, with completion scheduled for September 10, 2025. This firm fixed-price delivery order, awarded on September 9, 2025, represents a non-competitive award under a larger indefinite delivery contract vehicle. The sensors will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $10,816.07 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order represents a pediatric or adult continuous glucose monitoring product delivery to support federal medical supply needs. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $19,652.04 for Freestyle Libre 3 Plus Sensors, with completion targeted for September 25, 2025. This non-competitive delivery order was issued on September 24, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors valued at $4,146.72 on September 19, 2025, with completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vendor, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,144.64 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The sensors will be performed at AmerisourceBergen's...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXFFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,143.30 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 19, 2025, with an ultimate completion date of September 22, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a small-value transaction for continuous glucose monitoring sensors, reflecting the DLA's ongoing medical supply procurement needs for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medical commodities globally, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The company's consistent receipt of competitively awarded contracts demonstrates its established capability to meet federal medical procurement requirements and support critical healthcare operations across the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 9/19/25 |